Salvia miltiorrhiza bge. (danshen) in the treating non-alcoholic fatty liver disease based on the regulator of metabolic targets

HIGHLIGHTS

• who: Lei Wang and Weidong Chen from the School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China, Anhui Province Key Laboratory of Chinese have published the research: Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets, in the Journal: (JOURNAL)
• what: The authors focus primarily on the significant metabolic targets associated with Danshen, including c-Jun N-terminal kinases (JNKs), SREBP-1c, ChREBP, PPARs, CYPs and the others, to provide Frontiers in Cardiovascular Medicine | www.frontiersin.org PHYTOCHEMISTRY OF DANSHEN The authors briefly presented . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.